Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GFAP þ1 staining was detected in a subpopulation of cells with a very characteristic morphology, as reported previously (Boer et al., 2010;Hol et al., 2003;Middeldorp et al., 2009b).”
From Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease (2014) · cites this paper as Hol et al., 2003
In the citing paper
“Four splice variants, GFAPDEx6, GFAPD164, GFAPD135, and GFAPDEx7, skip sequences in exon 6/7, and were identified in AD tissue, focal lesions assocated with chronic epilepsy, and a specific human astrocyte subtype (Boer et al., 2010;Hol et al., 2003;Kamphuis et al., 2012;Middeldorp et al., 2009b).”
From Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease (2014) · cites this paper as Hol et al., 2003
In the citing paper
“These splice variants encode for a frameshifted GFAP protein, termed GFAP þ1 , with a frameshifted carboxyterminus against which we have raised a specific antibody named GFAP þ1 (Hol et al., 2003;Middeldorp et al., 2009b).”
From Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease (2014) · cites this paper as Hol et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“In this study, we focused on the human enthorinal cortex and hippocampus, since this area is the earliest and most affected area in AD”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Oligodendrocyte Precursor Cells Reprogrammed to Become Multipotential CNS Stem Cells
Kondo, T., & Raff, M. (2000) · Science · doi:10.1126/science.289.5485.1754 · Cited by 878 · cited 1×
“In addition, it has been shown that oligodendrocyte precursor cells can revert to multipotential neural stem cells, which can differentiate in neurons and astrocytes”
BackgroundThe cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859
Ott, A., Breteler, M. M. B., van Harskamp, F., Claus, J. J., van der Cammen, T. J. M., Grobbee, D. E., & Hofman, A. (1995) · BMJ · doi:10.1136/bmj.310.6985.970 · Cited by 792
Eng, L. F. (1985) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(85)80063-1 · Cited by 734 · cited 1×
“GFAP is the major component of the intermediate filaments in mature astrocytes”
BackgroundIdentification of a multipotent astrocytic stem cell in the immature and adult mouse brain
Laywell, E. D., Rakic, P., Kukekov, V. G., Holland, E. C., & Steindler, D. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250471697 · Cited by 721 · cited 1×
“The main question is why hippocampal neurons in AD patients start expressing a glia-specific transcript? It has been reported before that multipotent astroglia can differentiate in either astrocytes or neurons”
BackgroundMutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease
Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. E., & Messing, A. (2001) · Nature Genetics · doi:10.1038/83679 · Cited by 688 · cited 1×
“13 Recently, it has been shown that mutations in the GFAP gene are associated with Alexander disease”
BackgroundDNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616 · cited 1×
“41 Recently, it was reported that hippocampal pyramidal neurons complete a full S-phase, demonstrating that DNA replication occurs in neurons before neuronal death”
Background
Cited by
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
Self-citationGlial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker
Yang, Z., & Wang, K. K. W. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.003 · Cited by 1,050
Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease
Goetzl, E. J., Mustapic, M., Kapogiannis, D., Eitan, E., Lobach, I. V., Goetzl, L., Schwartz, J. B., & Miller, B. L. (2016) · The FASEB Journal · doi:10.1096/fj.201600756r · Cited by 386
Intermediate filaments: primary determinants of cell architecture and plasticity
Herrmann, H., Strelkov, S. V., Burkhard, P., & Aebi, U. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38214 · Cited by 335
Revisiting astrocyte to neuron conversion with lineage tracing in vivo
Wang, L.-L., Serrano, C., Zhong, X., Ma, S., Zou, Y., & Zhang, C.-L. (2021) · Cell · doi:10.1016/j.cell.2021.09.005 · Cited by 329
Rapid and efficient in vivo astrocyte-to-neuron conversion with regional identity and connectivity?
Wang, L.-L., Garcia, C. S., Zhong, X., Ma, S., & Zhang, C.-L. (2020) · doi:10.1101/2020.08.16.253195 · Cited by 328
Chen, Y.-C., Ma, N.-X., Pei, Z.-F., Wu, Z., Do-Monte, F. H., Keefe, S., Yellin, E., Chen, M. S., Yin, J.-C., Lee, G., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.003 · Cited by 312
Kamphuis, W., Mamber, C., Moeton, M., Kooijman, L., Sluijs, J. A., Jansen, A. H. P., Verveer, M., de Groot, L. R., Smith, V. D., Rangarajan, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042823 · Cited by 303
Self-citationKamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.035 · Cited by 269
Self-citationCommon genetic variation influencing human white matter microstructure
Zhao, B., Li, T., Yang, Y., Wang, X., Luo, T., Shan, Y., Zhu, Z., Xiong, D., Hauberg, M. E., Bendl, J., et al. (2021) · Science · doi:10.1126/science.abf3736 · Cited by 231
“Integrating the GWAS of white matter with these clinical outcomes may help us to understand the underlying mechanisms that lead to the changes in brain structural connectivity and risk of brain disorders.”
BackgroundEnteric GFAP expression and phosphorylation in Parkinson's disease
Clairembault, T., Kamphuis, W., Leclair‐Visonneau, L., Rolli‐Derkinderen, M., Coron, E., Neunlist, M., Hol, E. M., & Derkinderen, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12742 · Cited by 191
Self-citationProteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain
Korolainen, M. A., Auriola, S., Nyman, T. A., Alafuzoff, I., & Pirttilä, T. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.021 · Cited by 133
Liu, C.-Y., Yang, Y., Ju, W.-N., Wang, X., & Zhang, H.-L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00193 · Cited by 131
“Besides, pyramidal neurons of the hippocampus of AD patients may also express GFAP∆135, GFAP∆164 and GFAP∆Ex6, which can be observed in aged controls and Down syndrome patients as well (Hol et al., 2003).”
BackgroundKim, D. K., Park, J., Han, D., Yang, J., Kim, A., Woo, J., Kim, Y., & Mook-Jung, I. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0234-4 · Cited by 95
Chen, W., Zheng, Q., Huang, Q., Ma, S., & Li, M. (2022) · eLife · doi:10.7554/elife.75636 · Cited by 89
Parsi, S., Smith, P. Y., Goupil, C., Dorval, V., & Hébert, S. S. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2015.33 · Cited by 83
Morphological changes in white matter astrocytes in response to hypoxia/ischemia in the neonatal pig
Sullivan, S. M., Björkman, S. T., Miller, S. M., Colditz, P. B., & Pow, D. V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.010 · Cited by 63
“Multiple splice variants of GFAP have been recently identified (Nielsen et al., 2002; Hol et al., 2003; Blechingberg et al., 2007).”
Postsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42
“We have detected several isoforms of glial fibrillary acidic protein (GFAP), which can be expressed by several cell types in the brain, including neurons [148].”
Neurochemical Profile of Dementia Pugilistica
Kokjohn, T. A., Maarouf, C. L., Daugs, I. D., Hunter, J. M., Whiteside, C. M., Malek-Ahmadi, M., Rodriguez, E., Kalback, W., Jacobson, S. A., Sabbagh, M. N., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2699 · Cited by 39
Isolation and culture of functional adult human neurons from neurosurgical brain specimens
Park, T. I.-H., Schweder, P., Lee, K., Dieriks, B. V., Jung, Y., Smyth, L., Rustenhoven, J., Mee, E., Heppner, P., Turner, C., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa171 · Cited by 28
“However, the traditional notion of MAP2 and GFAP mutual exclusivity has been challenged in vivo (Hol et al. , 2003).”
de Souza, R. F., Augusto, R. L., de Moraes, S. R. A., de Souza, F. B., Gonçalves, L. V. D. P., Pereira, D. D., Moreno, G. M. M., de Souza, F. M. A., & Andrade-da-Costa, B. L. D. S. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00157 · Cited by 16
Tanahashi, H., & Tabira, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.033 · Cited by 11
Metadata
- Authors
- Hol, E. M., Roelofs, R. F., Moraal, E., Sonnemans, M. A. F., Sluijs, J. A., Proper, E. A., de Graan, P. N. E., Fischer, D. F., & van Leeuwen, F. W.
- Venue
- Molecular Psychiatry
- Published
- 2003-08-21
- Volume
- 8
- Issue
- 9
- Pages
- 786-796
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2045492362
- Cited by
- 165
- References
- 42
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.